3B. Hygriv Rao,Sanjeev Saksena. Impact of “hybrid therapy” on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation[J] 2007,Journal of Interventional Cardiac Electrophysiology(2):127～136
4Benjamin J. Scherlag,Hiroshi Nakagawa,Warren M. Jackman,William S. Yamanashi,Eugene Patterson,Sunny Po,Ralph Lazzara. Electrical Stimulation to Identify Neural Elements on the Heart: Their Role in Atrial Fibrillation[J] 2005,Journal of Interventional Cardiac Electrophysiology(1):37～42
4AFFIRM First Antiarrhythmic Drug substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug [J]. J Am Coll Cardiol, 2003, 42 (1): 20-29.
5Daoud EG, Hummel JD, Augostini R, et al. Effect of verapanmil on immediate recurrence of atrial fibrillation [J]. J Cardiovasc Electrophysiol, 2000, 11 (11): 1231-1237.
7Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an inde pendent risk factor for stroke: the Framingham Study [J]. Stroke, 1991, 22 (8): 983-988.
9Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial [J]. Lancet, 2000, 356 (9244): 1789-1794.
